LegalView Reports Mine Safety and Health Administration's Reduction of Asbestos Permissible Exposure Allowances by Nearly 95 Percent
March 12, 2008 (PRLEAP.COM) Health NewsDenver, CO - LegalView.com, the number one resource for everything legal on the Web, recently reported reduced asbestos exposure allowances for mine workers. The Mine Safety and Health Administration (MSHA) lowered the permissible exposure limits (PEL) from 2 asbestos fibers per cubic centimeter of air (f/cc) during an eight hour, time weighted average (TWA) full shift to 0.1 f/cc at all metal/nonmetal mines, surface coal mines and surface areas of underground coal mines. To learn more details about PEL and asbestos limits, readers may want to contact a mesothelioma lawyer who can provide details on these new limits and rules.
Mesothelioma cancer takes several years and even decades to develop and is largely misdiagnosed because of its similarities in symptoms to other diseases. Individuals who have been diagnosed with the cancer should contact an experienced mesothelioma law firm to learn about potential compensation for medical bills that can be received when filing and developing mesothelioma.
These new lower limits will take effect on April 29. And while MSHA agrees with earlier findings from the Occupational Safety and Health Administration (OSHA) that felt "there is a remaining risk of material impairment of health or functional capacity" at this level, the MSHA feels that the allowance is a practical lower limit and they will continue to monitor workers' health. For those who will be affected by this new ruling it is advisable to contact a mesothelioma attorney to better understand the legal ramifications of this new ruling.
LegalView offers the most up-to-date news on mesothelioma and asbestos as well as on additional legal and medical issues affecting millions of Americans each year. Additional topics include information on Baxter's Heparin, Trasylol Aprotinin and Chantix. Heparin, manufactured by the Baxter Healthcare Corporation, is a blood-thinning agent used during surgical procedures such as heart surgery. Medical professionals have been using Heparin since the 1930s, but most recently sales were halted and a Heparin recall occurred because of alleged serious allergic reactions to the injection of the drug in patients during surgery. To learn more about this visit, http://baxter-heparin.legalview.com/.
Similar to Heparin are Trasylol and Chantix in that both are prescription drugs, which have recently come under fire for controversial side effects. Trasylol is used to control blood clotting during surgical procedures but has been discovered by the U.S. Food and Drug Administration (FDA) to be linked to serious Trasylol reactions among patients. Chantix is a smoking cessation drug that has been linked to nearly 40 suicides among those taking the prescription drug, according to press reports. Additionally, Chantix side can include psychotic behaviors, suicidal tendencies and depression, according to the FDA.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.